Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.
Hodo
Yuji
Y
Tsuji
Kirokazu
K
Mizukoshi
Eishiro
E
Yamashita
Tatsuya
T
Sakai
Akito
A
Nakamoto
Yasunari
Y
Honda
Masao
M
Kaneko
Shuichi
S
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D006526:Hepatitis C / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D012008:Recurrence; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000139:chemically induced*; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D012254:Ribavirin; D009173:Mycophenolic Acid